Shares of Pluri Inc. (NASDAQ:PLUR – Get Free Report) traded down 2.8% during trading on Wednesday . The company traded as low as $4.33 and last traded at $4.45. 4,272 shares traded hands during trading, a decline of 77% from the average session volume of 18,389 shares. The stock had previously closed at $4.58.
Pluri Price Performance
The business’s 50-day simple moving average is $4.90 and its 200 day simple moving average is $5.25. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44. The company has a market capitalization of $25.57 million, a P/E ratio of -0.76 and a beta of 1.64.
Pluri Company Profile
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Further Reading
- Five stocks we like better than Pluri
- What to Know About Investing in Penny Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
- 3 Monster Growth Stocks to Buy Now
- Power Play: Japan’s Top Auto Stocks Eye Historic Merger
- ETF Screener: Uses and Step-by-Step Guide
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
